Page last updated: 2024-09-04

docetaxel anhydrous and Cystadenocarcinoma, Mucinous

docetaxel anhydrous has been researched along with Cystadenocarcinoma, Mucinous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Schrijvers, D; van Dam, P; van Oosterom, A	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Cystadenocarcinoma, Mucinous

Article	Year
CA 125: a misleading tumor marker? International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1996, Volume: 55, Issue:2 Topics: Antineoplastic Agents, Phytogenic; CA-125 Antigen; Cystadenocarcinoma, Mucinous; Docetaxel; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	1996

Article

Year

CA 125: a misleading tumor marker?

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1996, Volume: 55, Issue:2

Topics: Antineoplastic Agents, Phytogenic; CA-125 Antigen; Cystadenocarcinoma, Mucinous; Docetaxel; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids

1996